Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700687 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
A Phase 1 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT00700687: Completed Phase 1 study, sponsored by POZEN.
NCT00700687 is a Phase 1 study that has completed, run by POZEN. The registered enrollment target is 90 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700687, a Phase 1 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Interventions
- DRUG PA32540
- DRUG PA32540 and celecoxib
- DRUG aspirin and [NSAID]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
What the finished NCT00700687 record still lists
NCT00700687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% higher).
The record links to 0 conditions, and to 3 interventions - of which PA32540 is the first listed.
NCT00700687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700687 about?
NCT00700687 is a clinical study titled "Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib". We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
What is the current status of trial NCT00700687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2008-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00700687?
The interventions under investigation include: PA32540 (DRUG), PA32540 and celecoxib (DRUG), aspirin and [NSAID] (DRUG).
Who is sponsoring clinical trial NCT00700687?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00700687's enrollment target sits among peer trials
90 628th of 2000 higher than 1,352 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia